Cargando…

The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study

Background: A growing body of research has shown that consumption of probiotics can improve symptoms associated with mood and anxiety disorders through activity of the gut-brain axis. However, the effects of probiotics have yet to be tested in a clinical sample of treatment-naïve patients diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallace, Caroline J. K., Milev, Roumen V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917127/ https://www.ncbi.nlm.nih.gov/pubmed/33658952 http://dx.doi.org/10.3389/fpsyt.2021.618279

Ejemplares similares

Olfactory Functioning and Depression: A Systematic Review
por: Taalman, Hannah, et al.
Publicado: (2017)

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2020)

The effects of probiotics on depressive symptoms in humans: a systematic review
por: Wallace, Caroline J. K., et al.
Publicado: (2017)

Response of Depression to Botulinum Toxin Treatment: Agitation as a Predictor
por: Milev, Roumen
Publicado: (2015)

Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review
por: Wallace, Caroline J. K., et al.
Publicado: (2017)

Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study
por: Rothärmel, Maud, et al.
Publicado: (2022)

Effects of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation on Serum Brain-Derived Neurotrophic Factor Levels in Patients with Depression
por: Gedge, Laura, et al.
Publicado: (2012)

Using electronically delivered therapy and brain imaging to understand OCD pathology: A pilot feasibility study
por: Stephenson, Callum, et al.
Publicado: (2023)

Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2022)

Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial
por: Abraham, Gaby, et al.
Publicado: (2007)

Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use
por: Hassan, Kazi, et al.
Publicado: (2022)

Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes
por: Lyra e Silva, Natalia de M., et al.
Publicado: (2019)

COVID-19 Pandemic: The Impact of COVID-19 on Mental Health and Life Habits in the Canadian Population
por: Iftene, Felicia, et al.
Publicado: (2022)

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

An Open Label Pilot Study of a Brief Psychosocial Intervention for Disaster and Trauma Survivors
por: O'Donnell, Meaghan Louise, et al.
Publicado: (2020)

Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
por: Wade, Alan G, et al.
Publicado: (2011)

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT
por: Dormegny-Jeanjean, Ludovic Christophe, et al.
Publicado: (2023)

Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study
por: Bowlus, Christopher L., et al.
Publicado: (2023)

Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study
por: Köck, Patrick, et al.
Publicado: (2021)

Efficacy of a Group Psychoeducation Treatment in Binge Eating Disorder: An Open-Label Study
por: Liquori, Silvia, et al.
Publicado: (2022)

Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders
por: Vaccarino, Anthony L., et al.
Publicado: (2023)

Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial
por: Tavares, Diego Freitas, et al.
Publicado: (2020)

Mechanisms of Cognitive Impairment in Depression. May Probiotics Help?
por: Dobielska, Maria, et al.
Publicado: (2022)

Multi-Watt Near-Infrared Phototherapy for the Treatment of Comorbid Depression: An Open-Label Single-Arm Study
por: Henderson, Theodore A., et al.
Publicado: (2017)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine
por: Gallai, Virgilio, et al.
Publicado: (2003)

Baseline depressive symptoms as predictors of efficacy and tolerability of the treatment with duloxetine: a network analysis approach
por: Maciaszek, Julian, et al.
Publicado: (2023)

Safety and Tolerability of Both Arm Ischemic Conditioning in Patients With Major Depression: A Proof of Concept Study
por: Wang, Zuowei, et al.
Publicado: (2020)

Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
por: Segura-Garcia, Cristina, et al.
Publicado: (2021)

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review
por: Sapkota, Alisha, et al.
Publicado: (2021)

Efficacy and tolerability of minocycline in depressive patients with or without treatment-resistant: a meta-analysis of randomized controlled trials
por: Qiu, Youjia, et al.
Publicado: (2023)

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
por: Alam, Mohammed Y., et al.
Publicado: (2014)

Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
por: Mago, Rajnish, et al.
Publicado: (2013)

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2021)

Systematic review of probiotics as an adjuvant treatment for psychiatric disorders
por: Forth, Evan, et al.
Publicado: (2023)

Prediction of Antidepressant Efficacy by Cognitive Function in First-Episode Late-Life Depression: A Pilot Study
por: Pan, Weigang, et al.
Publicado: (2022)

Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study
por: Robillard, Rebecca, et al.
Publicado: (2018)

Relationship Between MR Spectroscopy-Detected Glutamatergic Neurometabolites and Changes in Social Behaviors in a Pilot Open-Label Trial of Memantine for Adults With Autism Spectrum Disorder
por: Nair, Neetu, et al.
Publicado: (2022)

The Correlation Between Probiotics and Anxiety and Depression Levels in Cancer Patients: A Retrospective Cohort Study
por: Ye, Ziqi, et al.
Publicado: (2022)

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
por: Glue, Paul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5d54t55vp564a5i7tj2ppc608s